Abivax (AAVXF) Retained Earnings (2021 - 2026)

Abivax has reported Retained Earnings for 6 years, with the latest figure at -$838.1 million in Q1 2026.

• On a quarterly basis, Retained Earnings fell 83.52% year-over-year to -$838.1 million in Q1 2026; TTM through Mar 2026 was -$838.1 million, a 83.52% decrease from a year earlier, with the FY2025 full-year figure at -$468.4 million, down 66.89% from the prior year.
• Retained Earnings was -$838.1 million for Q1 2026 at Abivax, down from -$468.4 million in the prior quarter.
• The five-year high for Retained Earnings was -$84.4 million in Q4 2022, with the low at -$838.1 million in Q1 2026.
• Average Retained Earnings over 5 years is -$392.9 million, with a median of -$456.7 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 92.92% in 2024, then tumbled 65.66% in 2025.
• Over 5 years, Retained Earnings stood at -$84.4 million in 2022, then sank by 72.27% to -$145.5 million in 2023, then tumbled by 92.92% to -$280.7 million in 2024, then sank by 66.89% to -$468.4 million in 2025, then sank by 78.93% to -$838.1 million in 2026.
• The last three Retained Earnings figures came in at -$838.1 million (Q1 2026), -$468.4 million (Q4 2025), and -$485.9 million (Q3 2025), per Business Quant data.